Injectable Drug Delivery Market worth $43.3 Billion by 2017

1. MarketsandMarkets Presents InjectableDrug Delivery Market worth $43.3 Billion by 2017 http://www.marketsandmarkets.com/Market-Reports/injectable-drug-delivery-market-150.html

2. The Injectables Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017,analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World. Browse >> 155data tables. 27 figures. in-depth TOC on Injectables Drug Delivery Market 2017. http://www.marketsandmarkets.com/Market-Reports/injectable-drug-delivery-market-150.html Early buyers will receive 10% customization on this report. Request to Download Free PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=150

3. The global injectable drug delivery technologies market was valued at $22.5 billion in 2012; it is expected to reach $43.3 billion by 2017 at a CAGR of 14.0% from 2012 to 2017. The injectable drug delivery technologies market is broadly categorized into two major segments, namely, devices technologies and formulation technologies. Based on product, the injectable drug delivery devices technologies market is further categorized into conventional injection devices, self injection devices, and others (microneedles, nanoneedles and blunt needle injections), while injectable drug delivery formulation technologies market is categorized into conventional drug delivery formulations and novel drug delivery formulations. Conventional injection devices segment accounted for the largest shareof the overall injectable drug delivery technologies market in 2012. Hormonal disorders commanded the largest share of 50.0% of the global injectable drug delivery technologies market in 2012; it is expected to grow at a CAGR of 13.9% to reach $21.6 billion by 2017. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices. Inquire Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=150

4. Contact Us Mr. RohanNorth - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252Tel: +1-888-6006-441Email: sales@marketsandmarkets.comMarketsandMarkets Bloghttp://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets

5. About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. http://www.marketsandmarkets.com/Market-Reports/injectable-drug-delivery-market-150.html